Benzinga - by Avi Kapoor, Benzinga Staff Writer.
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Tuesday.
Shares of Blue Bird Corporation (NASDAQ: BLBD) shares rose sharply during Tuesday’s session after the company reported better-than-expected financial results for its fourth quarter and increased its FY24 revenue forecast.
Blue Bird reported quarterly earnings of 66 cents per share, exceeding the analyst expectations of 48 cents. Revenue clocked in at $302.96 million which beat the analyst consensus estimate of $290.11 million.
Blue Bird shares gained 9.1% to $23.80 on Tuesday.
Here are some other big stocks recording gains in today’s session.
- Icosavax, Inc. (NASDAQ: ICVX) rose jumped 47.1% to $15.43 after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion. Concurrently, Icosavax released topline interim results for its Phase 2 study of IVX-A12, a combination virus-like particle (VLP) vaccine candidate targeting both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
- Gaotu Techedu Inc. (NYSE: GOTU) gained 18% to $3.4650.
- Intchains Group Limited (NYSE: ICG) rose 13.5% to $10.16.
- Oil-Dri Corporation of America (NYSE: ODC) jumped 12.2% to $66.09 following first-quarter results.
- Bitfarms Ltd. (NASDAQ: BITF) gained 9.9% to $2.4950.
- CAVA Group, Inc. (NYSE: CAVA) rose 9.8% to $35.68.
- Cassava Sciences, Inc. (NASDAQ: SAVA) gained 9.4% to $30.32.
- Eagle Bulk Shipping Inc. (NYSE: EGLE) climbed 9.2% to $50.42. Star Bulk and Eagle Bulk Shipping announced plans to combine.
- Innoviz Technologies Ltd. (NASDAQ: INVZ) rose 8.6% to $2.49.
- MorphoSys AG (NASDAQ: MOR) surged 8.6% to $9.59. MorphoSys recently announced results from the Phase 3 MANIFEST-2 study investigating pelabresib in combination with the JAK inhibitor ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis.
- Digital Turbine, Inc. (NASDAQ: APPS) rose 7.8% to $6.58.
- Disc Medicine, Inc. (NASDAQ: IRON) gained 7.8% to $65.84. Disc presented updated results from Phase 2 BEACON study of bitopertin and other programs at the 65th ASH Annual Meeting.
- BRP Group, Inc. (NASDAQ: BRP) rose 7% to $20.74. Raymond James upgraded BRP Group from Outperform to Strong Buy and announced a $30 price target.
- MoneyLion Inc. (NYSE: ML) gained 6.4% to $44.41.
Now Read This: Bitcoin, Ethereum Record Losses; FTX Token Becomes Top Loser
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.